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Abstract
Background: Aroclor 1254 is a well-known hepatotoxin and consists of a complex mixture of
polychlorinated biphenyls (PCBs), some of which have the ability to activate the aryl hydrocarbon
receptor (AhR) and other transcription factors (TFs). Altered transcription factor expression
enables activation of promoters of many genes, thereby inducing a regulatory gene network. In the
past, computational approaches were not applied to understand the combinatorial interplay of TFs
acting in concert after treatment of human hepatocyte cultures with Aroclor 1254. We were
particularly interested in interrogating promoters for transcription factor binding sites of regulated
genes.
Results: Here, we present a framework for studying a gene regulatory network and the large-scale
regulation of transcription on the level of chromatin structure. For that purpose, we employed
cDNA and oligomicroarrays to investigate transcript signatures in human hepatocyte cultures
treated with Aroclor 1254 and found 910 genes to be regulated, 52 of which code for TFs and 47
of which are involved in cell cycle and apoptosis. We identified regulatory elements proximal to
AhR binding sites, and this included recognition sites for the transcription factors ETS, SP1, CREB,
EGR, NF-kB, NKXH, and ZBP. Notably, ECAT and TBP binding sites were identified for Aroclor
1254-induced and E2F, MAZ, HOX, and WHZ for Aroclor 1254-repressed genes. We further
examined the chromosomal distribution of regulated genes and observed a statistically significant
high number of gene pairs within a distance of 200 kb. Genes regulated by Aroclor 1254, are much
closer located to each other than genes distributed randomly all over the genome. 37 regulated
gene pairs are even found to be directly neighbored. Within these directly neighbored gene pairs,
not all genes were bona fide targets for AhR (primary effect). Upon further analyses many were
targets for other transcription factors whose expression was regulated by Aroclor 1254
(secondary effect).
Conclusion: We observed coordinate events in transcript regulation upon treatment of human
hepatocytes with Aroclor 1254 and identified a regulatory gene network of different TFs acting in
concert. We determined molecular rules for transcriptional regulation to explain, in part, the
pleiotropic effect seen in animals and humans upon exposure to Aroclor 1254.
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Background
Transcription factors (TFs) play a decisive role in regula-
tory gene networks. By interacting with specific DNA-
binding elements (TF binding sites) transcriptional activa-
tion of targeted genes can be initiated. The expression
and/or activity of TFs may be regulated in a cell type- or
tissue-specific or in a cell cycle-dependent manner and
can be changed by different environmental influences [1].
Some TFs regulate their own transcription in a feed-back
loop [2].
A well-understood ligand-activated nuclear transcription
factor is aryl hydrocarbon receptor (AhR) [3]. Prior to acti-
vation through a variety of toxins such as 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD), polycyclic aromatic
hydrocarbons, combustion products, and numerous phy-
tochemicals including flavonoids and indole-3-carbinol
(I3C), AhR is found in the cytosol in association with heat
shock protein HSP90 and HSP90 accessory proteins. Lig-
and binding releases these proteins from their complex
and promotes nuclear translocation. In the nucleus, the
ligand-activated AhR forms a heterodimeric complex with
aryl hydrocarbon nuclear translocator (ARNT) [4]. The
complex binds to aryl hydrocarbon response elements
(AhRE) – also known as xenobiotic response elements
(XRE) and dioxin response elements (DRE) -, which func-
tion as cis-acting enhancers in the regulatory domains of
targeted genes, some of which are collectively known as
the AhR gene battery [5]. Negative regulation of gene
expression through AhR signaling is also known [6], but
the mechanisms by which different genes are either
induced or repressed after binding of activated AhR to
cognate recognition sites in gene promoters remains
uncertain. This is of particular importance, as ligands of
AhR elicit a broad spectrum of biochemical and toxicolog-
ical effects including teratogenesis, immunosuppression
due to thymic involution, and tumor promotion [7].
The importance of AhR in cell cycle regulation and apop-
tosis has, however, only just begun to be realized [5], and
there is evidence for AhR to be directly involved in the
transcriptional regulation of genes participating in cell
cycle regulation [8].
The metabolism of endogenous and exogenous substrates
by P450 enzymes (two of which are members of the AhR
gene battery) has been shown to cause reactive oxygen-
ated metabolite (ROM)-mediated oxidative stress. Oxida-
tive stress is a major signal in triggering apoptosis;
however, the precise mechanism, or molecules, determin-
ing the cell's decision for either apoptosis or continuation
of the cell cycle remains to be elucidated.
Furthermore, the importance of the chromosomal locali-
zation of genes with respect to transcriptional regulation
has also just begun to be realized. Many co-expressed,
non-homologous genes are known to be clustered on
chromosomes, implying their co-regulation. The posi-
tional clustering of co-expressed genes is common in
prokaryotes (operons) and was recently described for Sac-
charomyces cerevisiae [9],  Caenorabditis elegans [10] and
Drosophila melanogaster [11,12]. Throughout the human
genome, it is often supposed that genes are randomly dis-
tributed, except for tandem duplicates. However, chromo-
somal domains of highly expressed genes have recently
been revealed in the human genome as well [13,14].
Here, we used high-density oligonucleotide and cDNA
microarray technology to analyze transcript signatures of
Aroclor 1254-treated human hepatocytes. For the assign-
ment of biological processes involving the Aroclor 1254-
regulated genes, the GOFFA library was used, which is part
of the public toxicogenomics software for microarray data
management and analysis, e.g. ArrayTrack [15]. This
library provides gene ontology information using the
standard vocabulary (terminology) of the Gene Ontology
Consortium. Specifically, we searched for novel transcrip-
tion factors for an improved understanding of the regula-
tory gene network modulated by Aroclor 1254. Next to an
identification of AhR binding sites in regulated genes, we
searched for additional TFs binding sites as to determine
combinatorial interactions and to determine the reason
for the level of genes being either induced or repressed.
We also examined the chromosomal distribution of Aro-
clor 1254-regulated genes to test for our hypothesis of
transcriptional regulation of co-localized genes on the
basis of regulation of neighborhood genes which are not
bona fide targets of AhR but are targets of other regulated
TFs. Therefore we report molecular rules for transcrip-
tional regulation of targeted genes to explain in part the
pleiotropic effect observed in animals and humans upon
exposure to Aroclor 1254.
Results
Analysis of high-density oligonucleotide microarray data
We used RNA from control and Aroclor 1254-treated
hepatocyte cultures oligonucleotide microarrays. The
complete data have been deposited in NCBIs Gene
Expression Omnibus (GEO) [16] and are accessible
through GEO Series accession number GSE5213. The
experiment revealed that 910 genes were regulated by Aro-
clor 1254. Aroclor 1254 treatment resulted in increased
expression of 465 genes (at least two-fold), and repressed
expression of 445 genes (by at least 50%), as compared to
controls. AhR activation by components of Aroclor 1254
was also confirmed by gene expression profiling with
cDNA arrays. Here, the expression ratio of CYP1A1 was
31.3, the expression ratio of CYP1A2 was 11.9 and the
expression ratio of UGT1A1 was 2.9 as compared to con-
trols. Further, AhR activation by components of AroclorBMC Genomics 2006, 7:217 http://www.biomedcentral.com/1471-2164/7/217
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1254 was confirmed by CYP1A1 Western blotting experi-
ments and by determining EROD enzyme activity (Figure
1). We found CYP1A1 protein expression and enzyme
activity to be clearly induced in cultures of human hepa-
tocytes after incubation with Aroclor 1254. These data
provide conclusive evidence for activation of AhR in cul-
tures of human hepatocytes treated with Aroclor 1254.
Cellular roles of Aroclor 1254-regulated genes
To assign the biological processes involving the Aroclor
1254-regulated genes, we used the GOFFA library, which
is a part of the public toxicogenomics software for micro-
array data management and analysis ArrayTrack [15]. This
library provides gene ontology information, using the
standard vocabulary (terminology) of the Gene Ontology
Consortium. We focused only on some particular biolog-
ical processes, as depicted in Figure 2, and separately
assigned the number of Aroclor 1254-induced and Aro-
clor 1254-repressed genes which are involved in these
processes. Corresponding to the number of biological
processes a particular gene is involved in, this gene can
appear in different processes. Comparison of induced and
repressed genes' involvement in the different biological
processes (Figures 2) demonstrates that there was prepon-
derance for Aroclor 1254-induced genes to be involved
more often in the gene/protein expression machinery, in
the intracellular signal cascade and in development,
whereas repressed genes were more often involved in
immune response and cell adhesion. This result reflects
the reaction of the cells to the changes of environmental
Confirmation of AhR activation by components of Aroclor 1254 by CYP1A1 western blotting experiments and by determining  EROD enzyme activity Figure 1
Confirmation of AhR activation by components of Aroclor 1254 by CYP1A1 western blotting experiments and 
by determining EROD enzyme activity. A: Western blot using an antibody against CYP1A1. Protein expression of 
CYP1A1 in cultures of human hepatocytes treated with three different concentrations of Aroclor 1254 (10 µM, 20 µM, and 50 
µM) for 72 h, respectively. Lane 1: control, untreated; lane 2: 10 µM Aroclor 1254; lane 3: 20 µM Aroclor 1254; lane 4: 50 µM 
Aroclor 1254. B: EROD-enzyme activity. Enzyme activity of CYP1A1 in cultures of human hepatocytes treated with 20 µM 
Aroclor 1254 for 24 h, 48 h and 72 h, respectively. The de-ethylation product resorufin was determined fluorometrically. 
Results are mean and SD of three dishes.
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influences, here especially the influence of the mixture of
xenobiotics (Aroclor 1254).
Aroclor 1254-regulated expression of transcription factors 
and genes involved in regulation of cell cycle and apoptosis
We focused on genes coding for transcription factors in
order to elucidate the regulatory gene network induced by
Comparison of Aroclor 1254-induced genes and Aroclor 1254-repressed genes in respect of their involvement in different bio- logical processes Figure 2
Comparison of Aroclor 1254-induced genes and Aroclor 1254-repressed genes in respect of their involvement 
in different biological processes. The different biological processes are given on the ordinate the number of genes involved 
in these processes is given on the abscissa. Red bars: Aroclor 1254-induced genes; green bars: Aroclor 1254-repressed genes.
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treatment of human hepatocytes with Aroclor 1254. We
further focused on genes coding for regulators of cell cycle
and apoptosis (for review of the role of AhR in cell cycle
control and apoptosis see [5]), even though only limited
information on the specific role of AhR is available [8].
28 out of 465 genes which are induced by Aroclor 1254
treatment are transcription factors (one of which does not
bind directly to the DNA, but rather is a co-regulator of
transcription). Many of these transcription factors are
stress-induced and transcriptional regulate genes which
are involved in apoptosis, cell cycle, development, mor-
phogenesis, and oncogenesis as described in Additional
file 2a. 22 out of 465 genes which are induced by Aroclor
1254 treatment are especially involved in regulation of
cell cycle and apoptosis. Additional file 2a depicts their
Entrez Gene identifier and their signal ratio and further-
more the classification and function of these transcription
factors. We also identified 24 out of 445 genes which are
repressed as transcription factors by Aroclor 1254 treat-
ment (five of which do not bind directly to the DNA, they
are rather co-regulators of transcription) and 25 genes
which are especially involved in regulation of cell cycle
and apoptosis. They are listed in Additional file 2b,
including their Entrez Gene identifier and signal ratio.
Moreover, this Table depicts the classification and func-
tion of the transcription factors. Many of these transcrip-
tion factors are transcriptional repressors and are involved
in the regulation of genes which play a role in cell cycle,
development and oncogenesis.
Promoter sequence analysis of Aroclor 1254-regulated 
transcription factors and of genes involved in regulation of 
cell cycle and apoptosis
After identification of the Aroclor 1254-regulated tran-
scription factors and genes involved in regulation of cell
cycle and apoptosis, we extracted their promoters from
public databases and analyzed them in respect of AhR
binding sites. For this purpose, we used a matrix which we
had recently constructed (TRANSFAC accession no.
M00778; id V$AHR_Q5) [17]. As controls, we used pro-
moters of randomly selected genes from the microarray
which were not influenced by Aroclor 1254-treatment
(relative expression value = 1.0). Two different cut-off val-
ues, qcut-off = 0.96 and qcut-off = 0.98, were chosen for com-
putational analysis. We applied two different cut-offs in
order to test for an increase of the fold occurrences by
using the more stringent cut-off value (qcut-off = 0.98). This
would be a conformation for the specificity of the matrix
used (see below and Table 1). The numbers of AhR bind-
ing sites in the promoters of Aroclor 1254-regulated tran-
scription factors are given in Additional file 2a and
Additional file 2b, respectively, whereas the numbers of
AhR binding sites in promoters of unregulated genes are
listed in Additional file 3.
The calculated fold occurrences of AhR sites in the ana-
lyzed gene promoters are given in Table 1. They describe
the number of AhR binding sites detected as a ratio with
regard to the number of gene promoters analyzed. Here,
the fold occurrence of the unregulated gene promoters is
Table 1: Fold occurrence of AhR binding sites in the promoters of Aroclor 1254-regulated genes. The occurrence value of AhR binding 
sites in the promoters of control genes is set to 1.
Transcription factors and co-regulators of transcription (52)
Control genes Aroclor 1254-induced Aroclor 1254-repressed
Matrix similarity cut-off 0.96
1 2.62 2.78
Matrix similarity cut-off 0.98
1 4.28 6.87
Genes involved in regulation of cell cycle (29)
Control genes Aroclor 1254-induced Aroclor 1254-repressed
Matrix similarity cut-off 0.96
1 2.38 2.44
Matrix similarity cut-off 0.98
1 6.43 3.99
Genes involved in apoptosis (18)
Control genes Aroclor 1254-induced Aroclor 1254-repressed
Matrix similarity cut-off 0.96
1 0.42 2.67
Matrix similarity cut-off 0.98
1 1.87 5.99BMC Genomics 2006, 7:217 http://www.biomedcentral.com/1471-2164/7/217
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set to 1. Using the lower cut-off value of 0.96, the fold
occurrences of the AhR sites of the analyzed promoters of
one group in total are clearly increased in comparison to
the fold occurrences of the AhR sites of the control gene
promoters in total, with the exception of Aroclor 1254-
induced genes involved in apoptosis. However, using the
more stringent matrix similarity cut-off value of 0.98, the
fold occurrences of the AhR sites in the promoters of all
Aroclor 1254-regulated genes including genes involved in
apoptosis is clearly increased as compared to promoters of
unregulated genes. This result once more confirms the
specificity of the AhR matrix used and is an indication for
a direct regulation by AhR of many of the genes analyzed.
In order to prove whether AREs/EpREs (antioxidant
responsive elements/electrophile responsive elements),
which belong to an AhR-independent chemoprotective
response system, also play a role in regulation of the ana-
lyzed promoters, we constructed an ARE weight matrix
using functional ARE-DNA sequences [18]. Further, we
applied this ARE matrix to analyze all extracted promoters
of Aroclor 1254-regulated genes (Aroclor 1254-regulated
transcription factors and genes involved in regulation of
cell cycle and apoptosis). No ARE could be detected (data
not shown). As positive control for the matrix we used the
rat GST-Ya gene promoter, which contains several ARE
recognition sites (data not shown).
Common frameworks in the promoters of Aroclor 1254-
regulated genes
We used the Genomatix software FrameWorker to extract
a common framework consisting of different transcrip-
tion factor recognition sequences proximal to AhR. This
tool is designed for the comparative analysis of promoter
sequences. FrameWorker returns the most complex mod-
els that are common to the input sequences. These are all
elements that occur in the same order and in a certain dis-
tance range in all (or a subset of) the input sequences.
Here, we aimed to identify further transcription factor
binding sites next to that one of the AhR in order to deter-
mine rules for AhR-mediated transcriptional regulation in
response to the treatment of human hepatocytes with Aro-
clor 1254. We further whished to identify differences
between Aroclor 1254-induced and -repressed promoters.
Because positive as well as negative regulation of gene
expression through AhR signaling is known, but the
mechanisms by which different genes are either induced
or repressed after binding of activated AhR to cognate rec-
ognition sites in gene promoters remains uncertain.
For this purpose we analysed Aroclor 1254-induced and
repressed promoters separately. The results are shown in
Table 2. Besides at least one AhR binding site, all Aroclor
1254-regulated gene promoters (induced and repressed)
were defined by ETS and SP1 binding sites. All Aroclor
1254-repressed gene promoters additionally contained
E2F binding sites. Furthermore, at least 90% of all ana-
lysed Aroclor 1254-regulated gene promoters, contained
CREB, EGR, ZBP, NF-kappaB, and NKXH binding sites.
Notably, 90% of the Aroclor 1254-induced gene promot-
ers were positive for ECAT and TBP, whereas 90% of the
Aroclor 1254-repressed genes contained MAZ, HOX, and
WHZ binding sites. Thus, Aroclor 1254-induced and -
repressed genes could be distinguished on the basis of
combinatory rules for transcription factor recognition
sequences. As control we analysed the promoters of genes
which were not regulated by Aroclor 1254 at all (see Addi-
tional file 3) by using the FrameWorker. 90 % of these
promoters were positive for binding sites of only one sin-
gle transcription factor: ETS. No model with at least 2 ele-
ments was found (data not shown).
Chromosomal localization of Aroclor 1254-regulated 
genes
For 448 out of 465 up-regulated genes and for 434 out of
445 repressed genes the chromosomal localization could
be determined. The relative distribution of Aroclor 1254-
regulated genes on the different chromosomes showed no
marked under- or overrepresentation for particular chro-
mosomes as compared to the distribution of all genes of
the genome mapped so far (Additional file 1: Here, chro-
mosomal distribution data for all genes were plotted
against Aroclor 1254-regulated genes) (Distribution of
genes on the Y chromosome could not be studied as data
from male and female donors were pooled).
Next, the distribution of Aroclor 1254-regulated genes on
the single chromosomes was delineated graphically. The
distribution of Aroclor 1254-regulated genes on the chro-
mosomes in comparison with the distribution of all genes
mapped so far is shown in Figures 3, 4 and 5. These graphs
provide the visual impression that many Aroclor 1254-
regulated genes are co-localized in proximal neighbor-
hood and they seem to form clusters within chromosomal
regions. However, it is known that genes in general are not
uniformly distributed in the genome, as shown in Figures
3, 4 and 5. In order to answer the question as to whether
Aroclor 1254-regulated genes are statistically significant
co-localized along the chromosomes, we calculated spe-
cifically the probability by which Aroclor 1254-regulated
genes occur within DNA windows of different sizes as
compared to the probability of all known mapped 27,400
genes (RefSeq transcripts) of the human genome to occur
within the same DNA windows. The results of this analy-
sis are depicted in Table 3. The numbers of observed pairs
of Aroclor 1254-regulated genes in the different window
sizes used and the mean of the numbers of pairs of genes
stemming from the 100 random lists in the different win-
dow sizes used are listed in Table 3. In this table also the
standard deviations of the mean values of the random listsBMC Genomics 2006, 7:217 http://www.biomedcentral.com/1471-2164/7/217
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are given, as well as the significances (p value), which
express the possibility by which such a result would
appear by chance. The significance was calculated by
using the binominal distribution. Table 3 depicts the
Table 3: Number of genes found in different window sizes: Comparison of the Aroclor 1254-regulated gene list (857 genes) with the 
mean of 100 randomized gene lists (857 genes, respectively).
WINDOW SIZES 
ANALYSED [KBP]
100 
RANDOMIZED 
GENE LISTS (857) 
(MEAN OF THE 
EXPECTED 
NUMBER OF 
GENES)
STANDARD 
DEVIATION
EXPECTED 
PROBABILITY [%]
AROCLOR 1254 
REGULATED 
GENES (857) 
(OBSERVED 
NUMBER OF 
GENES)
SIGNIFICANCE (P 
VALUE)
50 30.01 5.5496 3.60 54 0.00001712
100 27.15 5.5621 3.26 33 0.03838451
200 44.9 7.0231 5.38 47 0.05681548
For each window size, the expected number of genes is shown along with the observed number of genes. The expected numbers of genes arise 
from the mean of 100 randomized gene lists comprising the same number of genes than the Aroclor 1254-regulated gene list. The expected 
probability [%] describes the number of genes as percentage for a given window size. Here, all genes from the randomized lists (857) are set to 100 
%. Further the p value is shown for obtaining such a result by chance using the binominal distribution.
Table 2: Definition of a common framework consisting of different transcription factor binding sites by analyzing 32 promoters of 
Aroclor 1254-regulated genes (transcription factors and genes involved in cell cycle regulation and apoptosis) using the Genomatix 
software FrameWorker. Only these promoters were applied, which possess at least one AhR binding site in its promoter, in order to 
identify candidate transcription factors which might cooperate with the AhR and in order to identify a common framework for 
promoters regulated by the AhR.
AROCLOR 1254-INDUCED GENES (14 SEQUENCES) AROCLOR 1254-REPRESSED GENES (18 SEQUENCES)
100% 90% 100% 90%
AhR AhR
ETS ETS
SP1 SP1
E2F
CREB CREB
EGR EGR
ZBP ZBP
NF-kB NF-kB
NKXH NKXH
MAZ
HOX
WHZ
ECAT
TBP
Binding sites of transcription factors which were identified in Aroclor 1254-induced promoters are marked in red, whereas binding sites of 
transcription factors which were identified in Aroclor 1254-repressed promoters are marked in blue. Binding sites of transcription factors which 
were present in the corresponding frequency (100 or 90%) in only induced or repressed promoters are underlined. These transcription factor 
binding sites discriminate induced from repressed promoters and vice versa. ETS: ETS transcription factors are known to regulate cellular growth 
and differentiation. SP1: SP1 transcription factors are ubiquitous and bind to GC-rich sequences in a large number of promoters. They can modulate 
transcription of specific genes through interactions with cell type- or stage-specific transcription factors. E2F: The E2F family plays a crucial role in 
the control of cell cycle. CREB: cyclic AMP (cAMP) response element-binding protein is a ubiquitous transcription factor that functions in glucose 
homeostasis and stimulates the expression of numerous genes in response to growth factors, hormones, neurotransmitters, ion fluxes and stress 
signals. EGR: EGR transcription factors are known to activate genes which are involved in differentiation and mitogenesis. ZBP: ZBP transcription 
factors are known to activate genes which are involved in cell growth arrest and cell death. NF-kB: cytokine- or stress-activated and stimulates the 
expression of genes involved in a wide variety of biological functions. NKXH: NKX homeodomain factors play critical roles in regulating tissue-
specific gene expression essential for tissue differentiation. MAZ: Myc-associated zinc fingers are ubiquitously expressed and can exert positive and 
negative control over the expression of target genes. HOX: The homeobox genes encode a highly conserved family of transcription factors that 
play an important role in morphogenesis. WHZ: Winged helix protein, involved in hair keratinization and thymus epithelium differentiation. ECAT: 
Enhancer CCAAT binding factors. A trimeric complex (nuclear factors YA-C (Y-box binding factors)), forming a highly conserved, ubiquitously 
expressed transcription factor that binds with high specificity to CCAAT motifs in the promoter regions in a variety of genes. TBP: TATA-binding 
protein factor binds directly to the promoter and nucleates the assembly of a transcriptionally competent preinitiation complex.BMC Genomics 2006, 7:217 http://www.biomedcentral.com/1471-2164/7/217
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Distribution of Aroclor 1254-regulated genes on the chro- mosomes 9–16 Figure 4
Distribution of Aroclor 1254-regulated genes on the 
chromosomes 9–16. The positions of the transcription 
start sites (in kbp) of the Aroclor 1254-regulated genes are 
marked on the upper horizontal black line as vertical blue 
bars, respectively. For comparison, the positions of the tran-
scription start sites of all genes mapped so far are marked on 
the lower horizontal black line as vertical blue bars, respec-
tively.
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Distribution of Aroclor 1254-regulated genes on the chro- mosomes 1–8 Figure 3
Distribution of Aroclor 1254-regulated genes on the 
chromosomes 1–8. The positions of the transcription start 
sites (in kbp) of the Aroclor 1254-regulated genes are 
marked on the upper horizontal black line as vertical blue 
bars, respectively. For comparison, the positions of the tran-
scription start sites of all genes mapped so far are marked on 
the lower horizontal black line as vertical blue bars, respec-
tively.
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over-representation of co-localized gene pairs within the
window sizes >0–50, >50–100 and >100–200 kbp. These
results are shown to be statistically highly significant (in
Table 3). Thus, genes which were regulated by Aroclor
1254 are much closer located to each other than genes dis-
tributed randomly all over the genome. RefSeq transcripts
which possess the same start site of transcription and thus
being alternatively spliced transcripts are included only
one time in the window size of 50 kbp. The other was
skipped from the analysis. Next, we analysed whether the
identified Aroclor 1254-regulated gene pairs are directly
neighbored (Note, 'directly neighbored gene pair' means
simply two genes adjacent to each other, in contrast to
'gene pair', which is localized within a set window).
Indeed, we found 37 gene pairs to be directly neighbored
on the chromosomes. The distances of the transcription
start sites of these directly neighbored gene pairs range
from 3 kb to 160 kb. Strikingly, the size of chromatin
domains, which are the units of transcriptional compe-
tences, varies from 5 kb to 200 kb [19]. A detailed descrip-
tion of the 37 directly neighbored gene pairs is shown in
Additional file 4.
In order to explore whether Aroclor 1254-regulated tran-
scription factors (see Additional file 2) also play a role in
the indirect regulation of genes being directly neighbored,
we used the corresponding available weight matrices from
the database TRANSFAC® Professional rel. 10.1 for the
analysis of all extracted promoters [exclusively, promoters
of genes, which are RefSeq annotated were extracted. The
beginning of the first exon, which also comprises the
5'UTR was considered to be a tentative TSS (transcription
start site)] of Aroclor 1254-regulated directly neighbored
genes [ATF3 (TRANSFAC® acc. number: M00513), v-Jun
(M00036), HOXB7 (M00998), SP2 (M00933), PBX1
(M00998, M01017), MAF/NRF1 (M00983), NF-kappaB
(M00208, M00774, M00054, M00194), PPARG2
(M00512, M00515), SOX18 (M01014) and BHLHB2
(M00997, M01034)]. Unfortunately, matrices of the other
Aroclor 1254-regulated transcription factors are not yet
available. The result of this analysis is shown in Table 4.
In 57 out of 73 analysed promoter sequences of the
directly neighbored genes binding sites of either AhR or/
and NF-kappaB or/and ATF3 or/and SP2 or/and PPARG2
or/and RFXANK or/and NRF1 or/and BHLHB2 were iden-
tified. In only 16 out of 73 analysed promoter sequences
no transcription factor binding site could be detected, nei-
ther an AhR binding site nor a binding site of an Aroclor
1254-regulated transcription factor, whose matrice was
available in the database TRANSFAC® Professional rel.
10.1. Notably, these genes might be targets of other Aro-
clor 1254-regulated transcription factors whose matrices
are not yet available. Thus, once a chromatin domain of
about 200 kbp is opened for the primary targets of Aroclor
1254 (e.g. AhR) the promoters of genes located within
this domain might be accessible also for secondary targets
of Aroclor 1254 (e.g. transcription factors other than AhR
whose expression is influenced by Aroclor 1254; see Addi-
tional file 2).
Distribution of Aroclor 1254-regulated genes on the chro- mosomes 17–22 and on the X chromosome Figure 5
Distribution of Aroclor 1254-regulated genes on the 
chromosomes 17–22 and on the X chromosome. The 
positions of the transcription start sites (in kbp) of the Aro-
clor 1254-regulated genes are marked on the upper horizon-
tal black line as vertical blue bars, respectively. For 
comparison, the positions of the transcription start sites of 
all genes mapped so far are marked on the lower horizontal 
black line as vertical blue bars, respectively.
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Discussion
AhR-mediated gene regulation has been defined by a
sequence of events by which the ligand-activated AhR
translocates into the nucleus and binds to AhR-DNA bind-
ing sites in the promoters, thereby altering gene expres-
sion controlled by these promoters [3]. This mode of
action limits the regulation of genes by the ligands of the
AhR, including polyhalogenated and polycyclic aromatic
hydrocarbons (PAHs), to those containing AhR binding
sites.
It has often been described in the literature, however, that
xenobiotics bound to the AhR cause a large number of
apparently unrelated biological and toxic effects [20], sug-
gesting that there exist other mechanisms to cause the
observed responses without acting through AhR binding
sites in the promoters of the corresponding genes.
In this study, we performed computational analyses in
order to elucidate the network of transcription factors and
their target genes in response to AhR activation or activa-
Table 4: Promoter analysis of 37 pairs of Aroclor 1254-regulated genes which are directly neighbored.
FIRST GENE 
(REFSEQ 
ACCESSION 
NUMBER)
FIRST GENE (AHR 
BINDING SITES)
FIRST GENE 
(BINDING SITES 
OF OTHER TFS)
SECOND GENE 
(REFSEQ 
ACCESSION 
NUMBER)
SECOND GENE 
(AHR BINDING 
SITES)
SECOND GENE 
(BINDING SITES 
OF OTHER TFS)
NM_003928 - - NM_015582 n.d.* n.d.*
NM_005334 - NFKB NM_003492 1 ATF3, SP2
NM_001643 - PPARG2 NM_032174 1 -
NM_021642 1 - NM_002155 - NFKB
NM_005807 - - NM_003292 - SP2
NM_006623 - - NM_005518 - PPARG2
NM_002061 1 SP2 NM_000350 - -
NM_144631 2 RFXANK NM_002707 1 PPARG2
NM_005911 - SP2, PPARG2 NM_000821 1 PPARG2
NM_016467 - PPARG2 NM_000534 - NFKB
NM_022173 1 - NM_016297 1 RFXANK, SP2
NM_006590 1 - NM_000542 - NRF1, PPARG2
NM_005141 - - NM_000508 - -
NM_000508 - - NM_000509 - -
NM_007104 - - NM_003214 1 SP2
NM_138446 1 - NM_006547 - BHLHB2
NM_003235 - - NM_006748 - -
NM_001261 - NFKB NM_004957 - PBX1, SP2
NM_005564 - NFKB NM_024112 - SP2
NM_005489 - SP2 NM_001261 - -
NM_004376 - NFKB NM_015960 - PPARG2
NM_005271 5 BHLHB2 NM_019054 3 -
NM_001572 - SP2, NFKB NM_021924 1 SP2
NM_052854 - SP2 NM_003646 - SP2, PPARG2
NM_006169 - RFXANK NM_019021 1 PPARG2
NM_021640 - - NM_015665 - NFKB
NM_003348 1 - NM_014050 - -
NM_002937 - PPARG2 NM_001145 - -
NM_006599 - NFKB, BHLHB2 NM_000903 1 NRF1
NM_003562 1 RFXANK NM_015528 1 NFKB, RFXANK
NM_002544 1 - NM_006495 - -
NM_018952 - NFKB, RFXANK NM_004502 2 RFXANK, BHLHB2
NM_007292 2 NFKB, BHLHB2 NM_001258 - PPARG2
NM_005359 - - NM_016626 1 SP2
NM_032377 - RFXANK NM_001611 2 BHLHB2, PPARG2
NM_018270 2 - NM_007346 - RFXANK, BHLHB2
NM_002626 2 SP2 NM_004928 1 SP2
* Promoter sequence was not available
ATF3: activating transcription factor 3, function unknown; BHLHB2: basic helix-loop-helix domain containing, class B2, anti-apoptosis, 
oncogenesis, hypoxia-induced; NFKB1: Nuclear Factor kappa B1, cytokine or stress-activated; NRF1: nuclear respiratory factor 1, cell growth, 
development; PPARG2: Peroxisome proliferator-activated receptor gamma, adipocyte differentiation, obesity, diabetes and cancer; RFXANK: 
regulatory factor X-associated ankyrin-containing protein, controls the cell type specificity and inducibility of MHC class II gene expression; SP2: 
Sp2 transcription factor, binds to GC box promoters elements.BMC Genomics 2006, 7:217 http://www.biomedcentral.com/1471-2164/7/217
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tion of as yet unknown factors by Aroclor 1254 in cultures
of human hepatocytes.
Activation and repression of transcription factors and the
ensuing changes in gene regulation seem to be hallmarks
of the molecular mechanisms of Aroclor 1254. Many of
them are candidates for being regulated directly by AhR,
through its binding to the corresponding in silico-identi-
fied DNA binding sites in their promoters. This proposed
network of transcription factors involved in regulation of
gene expression under direct or indirect influence by the
AhR is depicted in Figure 6.
In spite of the considerably higher fold occurrence of AhR
binding sites in the whole of Aroclor 1254-regulated gene
promoters analyzed as compared to non-influenced gene
promoters, many of them possess no AhR binding sites at
all. These genes might be regulated by Aroclor 1254 for
various reasons: 1) The changes in the expression of these
genes might be secondary effects, maybe through the
influence of transcription factors the expression of which
is regulated by AhR directly. Thus, the directly regulated
transcription factors seem to be the basis for the regula-
tory gene network induced by Aroclor 1254, through the
ensuing regulation of their target genes. 2) The changes in
the expression of these genes might also be direct effects
through an as yet unknown influence of Aroclor 1254 on
other transcription factors. Parallel activity of activated
TFs would be plausible causes for the pleiotropic effects
seen in animals upon treatment with PCBs. 3) Further-
more, it is known that functional AhR sites may be situ-
ated in the promoter regions of the AhR target genes, in
their introns as well as in far upstream and downstream
non-coding regions around the genes. In 2004, however,
we could demonstrate that within the window of -1000
bp upstream from the start of transcription AhR sites
could be observed with the highest frequency in AhR-reg-
ulated genes [17]. For that purpose, we decided to analyze
exclusively these regions of the promoters. Nevertheless,
we cannot exclude the possibility that we lose informa-
tion by this means. 4) These genes might also be regulated
through co-localization to directly regulated genes within
a chromatin domain (detailed discussion see below).
In spite of using an AhR matrix, the quality of which has
been demonstrated to be high [17], it must be mentioned
that the in silico identification of transcription factor bind-
ing sites in DNA sequences is not a sufficient proof for
binding of the corresponding factor in vivo. Moreover, in
some cases binding of transcription factors in vivo occurs
in promoters of genes whose expression is not altered
[21].
Despite this limitation the computational analysis of
microarray data reveal novel insight into the regulation of
networks of TFs acting in concert.
Indeed, one of the Aroclor 1254-induced transcription
factors is NF-kappaB (p105). NF-kappaB is a key regulator
of immune, inflammatory, and acute phase responses and
is also involved in the control of cell proliferation, apop-
tosis, and oncogenesis. NF-kappaB is known to control
many physiological functions adversely affected by AhR
ligands. Remarkable progress has been made in under-
standing the signal transduction pathways that lead to
activation of NF-kappaB factors and consequent induc-
tion of gene expression [22]. In this study, expression of
NF-kappaB was induced about 11-fold by Aroclor 1254.
We identified a single AhR binding site in its gene pro-
moter. Therefore, the transcription might be induced
through binding of activated AhR directly. The existing lit-
erature provides no information regarding activation of
NF-kappaB gene expression by AhR. However, a recent
study showed physical interaction and mutual functional
repression between AhR and NF-kappaB [23]. Protein-
Scheme of proposed network of transcription factors  involved in regulation of gene expression under direct or  indirect influence by the AhR Figure 6
Scheme of proposed network of transcription factors 
involved in regulation of gene expression under 
direct or indirect influence by the AhR. This network of 
transcription factors may explain the regulation of several 
genes that are not direct targets of AhR. Their regulation can 
be mediated through other TFs whose expression is regu-
lated directly by AhR.
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protein interactions between TFs are a further important
mode of action to increase their regulatory repertoire.
In the past few years, the importance of combinatorial reg-
ulation of transcription by networks of transcription fac-
tors has begun to be realized. In this study, we identified
several transcription factor binding sites occurring proxi-
mal to AhR in the Aroclor 1254-regulated promoters,
amongst them NF-kappaB. They belong to a common
framework of transcription factors acting in concert in
response to Aroclor 1254. Thus, also in transcriptional
regulation, AhR and NF-kappaB seem to work together.
Moreover, CREB and SP1 were found to be part of this
framework. The CREB transcription factor is a member of
the leucine zipper family. This protein binds as a
homodimer to the cAMP-responsive element, an octa-
meric palindrome. The protein is phosphorylated by sev-
eral protein kinases and induces transcription of genes in
response to stimulation of the cAMP pathway. In this
study, CREB was shown to be induced by Aroclor 1254,
maybe directly through binding of AhR to the in silico-
identified AhR binding sites in its promoter. The tran-
scription factor Sp1, which was not determined on the
Aroclor 1254 microarray, is a DNA-binding protein which
interacts with a variety of gene promoters containing GC-
box elements and is known to physically and functionally
interact with AhR in promoters of several genes in which
SP1 plays an important role in basal gene expression [24].
Moreover, a functional synergism of SP1 and the nuclear
factor Y (ECAT) in transcriptional stimulation of the rat
pyruvate kinase M (PKM) gene could recently be demon-
strated [25]. SP1 and NF-Y (ECAT) stimulate transcription
of the PKM gene via their interactions. Here, we found SP1
binding sites in 100 % of Aroclor 1254-induced as well as
in 100 % of repressed gene promoters proximal to AhR
binding sites, but we found ECAT binding sites exclusively
in 90 % of the induced gene promoters and not in
repressed promoters. Therefore, the induction of AhR-reg-
ulated transcription might also be the result of the inter-
play between SP1 and ECAT/NF-Y.
Furthermore, a recent study demonstrated that AhR forms
a complex and synergizes with Retinoblastoma Protein
(RB) to repress E2F-dependent transcription and cell cycle
progression [26]. Again, a very recent study demonstrated
that AhR-mediated gene repression requires combinato-
rial interactions at E2F-reponsive promoters, leading to
the repression of E2F-dependent, S phase-specific genes
[27]. By analogy, we showed E2F binding sites to be part
of a common framework of all Aroclor 1254-repressed
gene promoters analyzed.
ATF3, here found to be induced by Aroclor 1254, is a tran-
scription factor that represses transcription from promot-
ers with ATF sites through stabilization of the binding of
inhibitory co-factors at the promoter [28]. ATF3deltaZip,
here found to be repressed by Aroclor 1254, is an alterna-
tively spliced form of ATF3 that encodes a truncated ATF3
which does not bind DNA, stimulates transcription and
antagonizes the action of ATF3 [29]. Antagonism of both
these splice forms is also reflected in the Aroclor 1254
reaction resulting from our microarray experiments, in
which ATF3 is induced whereas ATFdeltaZip is reduced by
Aroclor 1254 (no AhR binding site could be identified in
its promoter, suggesting an indirect effect).
Another transcription factor, the expression of which was
induced about three-fold by Aroclor 1254, was the perox-
isome proliferator-activated receptor gamma (PPARγ).
This is one example of a soluble intracellular receptor,
which is important in mediating toxic responses and is
associated with hepatocarcinogenesis in rodents [29].
Concerning Aroclor 1254-regulated genes involved in the
regulation of cell cycle and apoptosis, some of them are
remarkable and will be discussed. In our microarray anal-
ysis, the cyclin-dependent kinase 9 (CDK9 or Sprouty2)
was induced 3.2-fold by Aroclor 1254. Sprouty2 is known
to attenuate epidermal growth factor receptor ubiquityla-
tion and endocytosis, and consequently enhances RAS/
ERK signaling [30]. Various intracellular signaling cas-
cades are altered in tumor cells. Among these, the receptor
tyrosine kinase RAS/ERK signaling pathway was found to
be constitutively active in a significant percentage of
human tumors (for review see [31]). Furthermore, the cell
cycle inhibitory protein p21 (Cip1) was found to be
induced 5.5-fold by Aroclor 1254. The carcinogenic poly-
cyclic aromatic hydrocarbon benzo [a]pyrene, which is a
high-affinity AhR ligand, is known to cause growth arrest
in 3T3 fibroblasts during the G1 phase of the cell cycle
[32]. We identified a potential AhR binding site in the
Cip1 promoter; hence, the induction of Cip1 by Aroclor
1254 could be a direct effect of AhR. Cdc25A, a phos-
phatase essential for G1-S transition, for cell cycle progres-
sion, which is known to compete against Cip1, was shown
here to be reduced by 50% upon Aroclor 1254-treatment.
To gain a better understanding of the expression of indi-
vidual genes in response to Aroclor 1254, it was useful to
analyze the corresponding promoter sequences for regula-
tory modules, especially transcription factor binding sites,
being responsible for quantitative changes in the expres-
sion. This resulted in models of transcriptional regulation,
either induction or repression, controlled by a special net-
work of regulatory modules. And some facts known from
the literature for single genes could be confirmed here in
silico for many genes (see above).
However, mapping the Aroclor 1254-induced transcrip-
tome back onto the genome was useful to get insight intoBMC Genomics 2006, 7:217 http://www.biomedcentral.com/1471-2164/7/217
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the large-scale regulation of transcription. Here, we found
that genes regulated by Aroclor 1254, are much closer
located to each other than genes distributed randomly all
over the genome, which raises the possibility of chroma-
tin structure being involved in the large-scale regulation of
transcription.
Chromatin is usually described as being divided into
"open" domains where genes have the potential to be
expressed through the accessibility of the corresponding
gene promoters for different transcription factors, and
domains of "closed" regions where gene expression is shut
down. The existence of co-expressed/co-localized gene
clusters is consistent with a model where large chromatin
regions would change their activity (openness) status in a
tissue-specific manner, allowing neighboring genes to be
transcribed or shut down in a coordinated way. In this
study, large chromatin regions might change their activity
(openness) status in response to the influence of Aroclor
1254. This means that, besides being controlled individu-
ally, e.g. through AhR, genes may also be subject to regu-
lation according to their location within the genome.
Thus, expression of co-localized genes might reflect rules
in chromatin remodeling and, as a consequence, gene
transcription. Notably, we corroborated our proposal by
promoter analyses of directly neighbored regulated genes.
Most of the promoters included binding sites of either
AhR or (a) transcription factor(s) whose expression was/
were found to be regulated by Aroclor 1254 (see Addi-
tional file 2 and Table 4).
Conclusion
Taken collectively, global gene regulation in response to
Aroclor 1254 seems to be the result of different coordinate
events (see Figure 7).
1: The Aroclor 1254-activated nuclear transcription factor
AhR influences the expression of different transcription
factors by binding to AhR recognition sites in correspond-
ing promoters. These transcription factors constitute the
basis of a regulatory gene network that again influences
the expression of different genes. It has to be kept in mind
here that also other transcription factors could well be pri-
mary targets of Aroclor 1254.
2: The Aroclor 1254-activated nuclear transcription factor
AhR seems to act in concert with other transcription fac-
tors, because a common framework of the corresponding
binding sites could be identified proximal to AhR in the
Aroclor 1254-regulated gene promoters. The combination
of co-acting transcription factors might be one reason for
the level of gene expression being either induced or
repressed. Here, it also has to be kept in mind that tran-
scription factors whose sites are found in the neighbor-
hood of AhR binding sites could well be primary targets of
Aroclor 1254.
3: Chromosomal localization seems to be important in
the large-scale regulation of mRNA transcripts in response
to Aroclor 1254. Hence, genes in neighborhood of direct
Aroclor 1254-induced transcriptional regulation (primary
effect), might be co-expressed through the accessibility of
their promoters for the transcription factors whose expres-
sion were influenced by Aroclor 1254 (secondary effect).
Our findings with AhR may well translate to a more gen-
eral principle of gene transcription, and with the advent of
microarray studies combined with well performed bioin-
formatics distinction of targeted gene transcription from
co-expression of nearby genes within a chromatin domain
becomes feasible.
Methods
Tissue and cultures
Approval was obtained from the ethics committee of the
Medical School of Hanover. Human hepatocytes were iso-
lated from surgical material. The liver specimens were
stored in ice cold physiologic saline solution and immedi-
ately transported to the laboratory. Vessels visible on the
cut surface were cannulated and the liver specimen was
perfused with 200 ml buffer I containing 8.3 g/l NaCl, 0.5
g/l Kcl, 2.4 g/l HEPES and 0.19 g/l EGTA at pH 7.4 and
37°C. This was followed by perfusion with 200 ml of
buffer II at pH 7.4 and 37°C. Buffer II consisted of 8.3 g/l
NaCl, 0.5 g/l Kcl, and 2.4 g/l HEPES. Thereafter, colla-
genase perfusion was performed initiated with 200 ml of
buffer III containing 100 µg collagenase type IV, 3.9 g/l
NaCl, 0.5 g/l Kcl, 2.4 g/l HEPES and 0.7 g/l CaCl2 × 2 H2O
at 37°C. The collagenase perfusate was recirculated. Flow
rates ranged between 20 to 50 ml and were adapted to the
size of the surgical specimen. Following perfusion, the
liver capsule was carefully removed and the cells were lib-
erated by gentle shaking of the liver into ice cold buffer IV.
Buffer IV contained 9.91 g/l Hanks buffered salt without
calcium and magnesium, 2.4 g/l HEPES and 2.0 g/l bovine
serum albumin. The resulting cell suspension was filtered
through a nylon mesh with 100 µm pore size and washed
three times with buffer IV at 4°C. Viability of the hepato-
cytes ranged between 85% and 95% as assessed by trypan
blue exclusion. On average, 1–5 × 109 cells were obtained
from one isolation procedure. Primary human hepato-
cytes were cultured enclosed in two layers of collagen as
described previously [33,34]. 1 ml collagen solution con-
taining 1.1 mg/ml collagen was used for coating one 60
mm Petri dish (Greiner, Frickenhausen, Germany). The
pH of the collagen was adjusted to 7.4 using a 10× DMEM
concentrate (Biochrom, Berlin, Germany). Thirty minutes
after coating the dishes, 2 × 106 hepatocytes per dish were
seeded. After two hours following seeding and cell attach-BMC Genomics 2006, 7:217 http://www.biomedcentral.com/1471-2164/7/217
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ment, culture medium was removed along with non-
adherent cells. After 24 h in culture, the medium was aspi-
rated and a second layer of collagen was pipetted on top
of the cells. After gelation of this second layer, culture
medium was added. Culture medium (2 ml) was changed
daily. The total volume of cell culture supernatant was 4
ml, including the hydrated collagen matrix volume of
about 2 ml.
Prior to treatment with polychlorinated biphenyls, cells
were allowed to recover from the isolation procedure for
4 to 5 days. Solutions of Aroclor 1254 at strength of 10
The coordinate events which resulted in gene regulation in response to Aroclor 1254 Figure 7
The coordinate events which resulted in gene regulation in response to Aroclor 1254. 1) The Aroclor 1254-acti-
vated nuclear transcription factor AhR influences the expression of different transcription factors by binding to AhR recogni-
tion sites in corresponding promoters. These transcription factors constitute the basis of a regulatory gene network that again 
influences the expression of different genes. Other transcription factors could also be primary targets of Aroclor 1254. 2) The 
Aroclor 1254-activated nuclear transcription factor AhR seems to act in concert with other transcription factors, because a 
common framework of the corresponding binding sites could be identified proximal to AhR in the Aroclor 1254-regulated 
gene promoters. The combination of co-acting transcription factors might be one reason for the level of gene expression being 
either induced or repressed. Other transcription factors whose sites are found in the neighborhood of AhR binding sites could 
well be primary targets of Aroclor 1254. 3) Chromosomal localization seems to be important in the large-scale regulation of 
mRNA transcripts in response to Aroclor 1254. Hence, genes in neighborhood of direct Aroclor 1254-induced transcriptional 
regulation (primary effect), might be co-expressed through the accessibility of their promoters for transcription factors whose 
transcription was altered by Aroclor 1254 (secondary effect).
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mg/ml were prepared in DMSO. These solutions were
diluted as necessary with the cell culture medium to
obtain doses of 20 µM Aroclor 1254. The final concentra-
tion of DMSO in the cell culture medium was 0.5% (v/v).
Cell cultures receiving 0.5% DMSO with the culture
medium were used as controls. After 72 h of treatment
with Aroclor 1254 cells and the collagen layer were imme-
diately frozen at -80°C.
RNA isolation and production of copy RNA
Total RNA was isolated using QIAGEN's RNeasy total
RNA isolation kit according to the manufacturer's recom-
mendations. 10 µg of total RNA were used for the synthe-
sis of double-stranded cDNA with SuperScript II RT.
Primer extension was performed using HPLC-purified T7-
(dT)24 (GenSet SA) as a primer. After clean-up, the double-
stranded cDNA was used for synthesis of biotin-labelled
cRNA (ENZO® BioArray High Yield RNA Transcript Labe-
ling Kit, Affymetrix). cRNA was purified with RNeasy spin
columns from QIAGEN and cleaved into fragments of 35–
200 bases by metal-induced hydrolysis.
Microarray experiments
Oligonucleotide microarrays were hybridized and washed
according to the manufacturer's recommendations as
detailed in [35]. With the NimbleGen platform (25 mer)
a total of 2 arrays were employed. Further, we employed
15 cDNA arrays containing 302 well-known genes with
known or suspected roles in drug oxidation/detoxifica-
tion, cell proliferation, tumor development, stress
response, signal transduction pathways (protein kinases,
cytokines), apoptosis and cell cycle arrest.
When starting with non-amplified RNA approximately 40
µg of total RNA were combined with a control RNA con-
sisting of an in vitro transcribed E. coli genomic DNA frag-
ment carrying a 30 nt poly(A)+-tail (EC17), and mRNA
was isolated (Oligotex mRNA Mini Kit, Qiagen). 0.8 µg
mRNA or 2 µg amplified RNA (aRNA) were diluted to 17
µl and combined with 2 µl of a second control RNA, a
mixture of the three different transcripts EC7, EC20, and
EC21. mRNA and aRNA were reverse transcribed by add-
ing a mix consisting of 8 µl 5 × First Strand Buffer
(GIBCO), 2 µl Primer-Mix (oligo(dT) and randomeres for
mRNA or randomeres only for aRNA) (MEMOREC), 2 µl
low C dNTPs (10 mM dATP, 10 mM dGTP, 10 mM dTTP;
4 mM dCTP), 2 µl FluoroLink™ Cy3/5-dCTP (amersham
pharmacia biotech), 4 µl 0,1 M DTT, and 1 µl RNasin (20–
40 U) (Promega). 1 µl (200 u) of SuperScriptII enzyme
was added, incubated at 42°C for 30 min followed by
addition of a further 1 µl of SuperScriptII enzyme and
incubated under the same conditions as detailed above.
0.5 µl of RNaseH (GIBCO) was added and incubated at
37°C for 20 min to hydrolyze RNA. Cy3 and Cy5 labeled
sample were combined and cleaned up using QIAquick™
(Qiagen). Eluents were concentrated in a speedVac at
45°C to obtain a volume of 10 µl. 10 µl of 2 × Hybridiza-
tion Solution (MEMOREC) pre-warmed at 42°C was
added. Hybridization was performed according to manu-
factures guidelines (MEMOREC). Briefly, cDNA-arrays
were heated at 98°C in distilled water for 2 min to dena-
ture double stranded DNA and immediately mixed with
96% Ethanol. Arrays were dried by centrifugation at 500 ×
g and placed into a dust free cassette. 20 µl of pre hybrid-
ization buffer was heated at 98°C for 2 min, cooled to
42°C, applied to the cDNA-array and sealed with cover
slip. The arrays were placed into an humidified hybridiza-
tion cassette (PIQOR-HybChamb, MEMOREC) and incu-
bated at 62°C for 30 min. The hybridization cassette was
cooled to 25°C, cover slips were removed from cDNA-
array and 20 µl of the labeled sample was directly applied
to the cDNA-array, again sealed with a cover slip and incu-
bated in the humidified hybridization chamber at 62°C
overnight. Arrays were washed twice with washing buffer
at 50°C, dried by centrifugation and stored in a dust free
cassette until read out.
Western blot analysis
Western blot analysis of human CYP monooxygenases
was done as described previously [36]. In the case of
CYP1A1 the monoclonal antibody mAb1A3-03 was pur-
chased from Rubitec, USA.
Analysis of microarray data
With both platforms applied the statistical analysis was
performed using the manufacturer's software and accord-
ing to its recommendations. The NimbleGen data have
been normalized as follows: each set of expression values
is divided by the standard deviation of that array only. The
corresponding expression values were the average differ-
ence values for each target. These are calculated as the
average of the signal intensities for the perfect match
probe (PM) minus the mismatch probe (MM). These
designs both used 10 probe pairs per target. Values that
differ from the mean by more than 2.5 standard devia-
tions are dropped from the calculation. The normalized
data were then rescaled to account for between chip vari-
ations. Here, the standard deviation of the whole set of
arrays were used to give us a scaling factor.
For further analysis of NimbleGen-high-density light-
directed oligonucleotide microarrays, we used the ratios
between the normalized intensity values for controls
(non-treated human hepatocytes) and the normalized
intensity values for Aroclor 1254-treated human hepato-
cyte cultures. A ratio of 1.0 means, that there was no
change at all. At first, we sorted the genes according to
their ratios. We further analyzed exclusively those genes
which were either up-regulated at least two-fold or down-
regulated at least two-fold. Up-regulated genes includedBMC Genomics 2006, 7:217 http://www.biomedcentral.com/1471-2164/7/217
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genes (1) with a control intensity value above 100 and an
Aroclor 1254 intensity value above 200, (2) with a control
intensity value between 0 and 100 and a difference of at
least 70 between the control and Aroclor 1254 intensity
values, or (3) with the control intensity value being absent
(= 0) and an Aroclor 1254 intensity value of at least 100.
Down-regulated genes included genes (1) with a control
intensity value above 100 and a difference of at least 70
between the control and Aroclor 1254 intensity values, or
(2) with a control intensity value above 100 and the Aro-
clor 1254 intensity value being absent (= 0).
In the case of cDNA arrays image capture and signal quan-
tification of hybridized PIQOR™ cDNA-arrays were done
with the ScanArray3000 (GSI Lumonics) and ImaGene
software Vers. 2.0 (BioDiscovery). For each spot, the local
signal was measured inside of a fixed circle of 350 µm
diameter and background was measured outside of the
circle within specified rings 40 µm in distance to the signal
and 40 µm in width. The signal and background was taken
to be the average of pixels between defined low and high
percentages of respective maximum intensity with per-
centage parameter settings for low/high being 85/97 % for
signal and 10/25 % for background respectively. Local
background was subtracted from signal to obtain the net
signal intensity and the ratio of Cy5/Cy3. Subsequently
the mean of the ratios of two corresponding spots repre-
senting the same cDNA was computed. The mean ratios
were normalized to the median of all mean ratios using
only spots for which the fluorescent intensity in one of the
two channels was 3 times the negative control. The nega-
tive control for each array was computed as the mean of
the signal intensity of two spots representing herring
sperm and two spots representing spotting buffer only.
Only genes displaying a 3 fold higher net signal intensity
in the control or treatment sample compared to the nega-
tive control were used for further analysis.
The biological processes involving the Aroclor 1254-regu-
lated genes were assigned by using the GOFFA library,
which is a part of the public toxicogenomics software for
microarray data management and analysis ArrayTrack
[15]. This library provides gene ontology information
using the standard vocabulary (terminology) of the Gene
Ontology Consortium. Furthermore, we used the NCBI
database Entrez Gene [37] and whenever necessary sur-
veying literature in order to determine genes affected by
Aroclor 1254 coded for transcription factors or regulators
of cell cycle and apoptosis. Aroclor 1254-regulated tran-
scription factors were classified according to the transcrip-
tion factor classification scheme of BIOBASE GmbH [42].
Sequence retrieval
The UCSC genome browser [38] was used to extract the
promoter regions of Aroclor 1254-regulated transcription
factor genes, genes involved in regulation of cell cycle and
apoptosis, Aroclor 1254-regulated directly neighbored
genes and promoter regions of control genes, the relative
expression values of which were 1.0. Exclusively promot-
ers of genes, which are RefSeq annotated, were extracted.
The beginning of the first exon, which also comprises the
5'UTR was considered to be a tentative TSS (transcription
start site) [43]. We extracted 1000 bp upstream and 100
bp downstream of TSS, respectively.
Promoter analysis
The most widely used method for recognition of tran-
scription factor binding sites is the application of posi-
tional weight matrices (PWMs) [39,40]. TRANSFAC®
Professional rel. 10.1 is the largest collection of weight
matrices for eukaryotic transcription factors [41,42] (BIO-
BASE GmbH, Wolfenbüttel, Germany). In this database,
three different weight matrices for AhR sites were stored
(acc. numbers: M00139, M00235, and M00237). In coop-
eration with BIOBASE, we recently constructed a novel
weight matrix on the basis of 25 known, experimentally
verified, genomic AhR binding sites (TRANSFAC®  acc.
number: M00778, id: V$AHR_Q5) [17]. This matrix was
used for searching potential AhR sites in the different pro-
moter sequence sets extracted (promoter sequences of
Aroclor 1254-regulated transcription factors, Aroclor
1254-regulated genes involved in regulation of cell cycle
and apoptosis, and control genes which are not influ-
enced by Aroclor 1254 at all). For this search, we
employed the MATCH™ algorithm calculating scores for
the matches by applying the so-called information vector
[44]. The cut-off values for matrix similarity (matrice
binding sequence: 11 bp) used were q > qcut-off = 0.96 and
q > qcut-off = 0.98 (the cut-off values for core similarity were
always set to 1.00/core binding sequence: GTGCG). The
matrix similarity cut-off is a score that describes the qual-
ity of a match between a matrix and an arbitrary part of
the input sequences. In addition, only those matches,
which score higher than or equal to the matrix similarity-
threshold appear in the output. The total number of AhR
matches within one sequence set was divided by the
number of genes of one set. The ratio of the control pro-
moter sequences was set to 1 and the other ratios were
compared to this fold occurrence. In order to analyze the
promoters of directly neighbored genes the MATCH™
algorithm was used, as well, applying the following matri-
ces: ATF3 (TRANSFAC®  acc. number: M00513), v-Jun
(M00036), HOXB7 (M00998), SP2 (M00933), PBX1
(M00998, M01017), MAF/NRF1 (M00983), NF-kappaB
(M00208, M00774, M00054, M00194), PPARG2
(M00512, M00515), SOX18 (M01014) and BHLHB2
(M00997, M01034). The cut-off values used for the NF-
kappaB and the PPARG2 matrices were default-cut-offs for
core and matrice similarity, respectively. For all other
matrices the cut-off value q > qcut-off = 1.00 for core similar-BMC Genomics 2006, 7:217 http://www.biomedcentral.com/1471-2164/7/217
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ity and the cut-off value q > qcut-off = 0.98 for matrix simi-
larity were used. In order to define a common framework,
we analyzed the promoter sequences for transcription fac-
tor binding sites with the programs MatInspector Profes-
sional and FrameWorker (Genomatix Software, Munich,
Germany [45]). The computational approaches were
based on the MatInspector program[39] using the selected
matrix library (vertebrate section)and optimized thresh-
olds.
Analysis of chromosomal localization
From the list of all 910 Aroclor 1254-regulated genes a list
of 857 genes was created, the chromosomal position of
which are known and which possess a RefSeq accession
number. The start positions of transcription of all RefSeq
transcripts of the human genome (= 27400) were down-
loaded from the NCBI genome browser MapViewer [46].
Out of this dataset 100 random lists possessing 857 Ref-
Seqs, respectively, were created. Distribution of both Aro-
clor 1254-regulated and all as yet mapped RefSeq
transcripts was subsequently visualized in Microsoft Excel
2000 (Figures 3, 4 and 5). The numbers of pairs of genes
for each of the lists that were located on the same chromo-
some within a distance of >0–50, >50–100 and >100–200
(window sizes) were calculated. The numbers obtained
from the Aroclor 1254-regulated gene list were compared
with the means obtained from the 100 random lists. To
determine if the observed (Aroclor 1254-regulated) num-
bers of adjacent pairs were significantly different from
those of expected adjacent pairs (100 random lists), the
binominal distribution, given by the formula
was used. In this formula n is the total number of RefSeq
transcripts in the gene lists (= 857), p is the probability of
a gene pair to be present in a single window size (expected
number of gene pairs in a single window size/834), k is
the observed number of gene pairs in a single window size
and q = 1-p.
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